Leocadin

Leakadine: an immunomodulatory drug from Latvia

Leakadine is an immunomodulatory drug produced by the Latvian pharmaceutical company Grindeks Public Joint Stock Company. The drug is used to stimulate immune processes and is widely used in combination antitumor therapy in adults, in dermatology, including psoriatic arthritis and erythematosis.

Leakadine is available in two dosage forms: lyophilized powder for the preparation of an injection solution and 0.1 g tablets. The drug contains components that help activate immune cells and improve their functions, which can help the body more effectively fight infections and tumors.

Like any other drug, Leakadine has contraindications and side effects. Contraindications for use are individual intolerance, leukopenia, thrombocytopenia, gastric and duodenal ulcers, stage II-III hypertension, thrombophlebitis. Side effects may include nausea, vomiting, leukopenia, thrombocytopenia, increased blood pressure and allergic reactions.

According to the literature, there is no information yet on the interaction of Leakadin with other drugs. There is also no data on overdose.

It is important to remember that before using any medication, you must consult with your doctor and strictly adhere to the prescribed dosage. If side effects occur, you should immediately consult a doctor and reduce the dose or discontinue the drug.

In conclusion, Leakadin is an immunomodulatory drug produced by the Latvian pharmaceutical company Grindeks Public Joint Stock Company. The drug is used to stimulate immune processes and can be useful in combination antitumor therapy and in dermatology. But, like any other drug, it has contraindications and side effects, so its use must be discussed and agreed with the attending physician.